Drug Trial Radar · NCT01304836
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
Last checked: Nov 19, 2026Latest source record: Nov 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,166
Actual
Start
Jan 22, 2011
Primary completion
May 22, 2013
Study completion May 22, 2013
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Feb 28, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.
Conditions
- Kidney Transplantation
Interventions
AdvagrafDrug
oral
Mycophenolate MofetilDrug
oral
SimulectDrug
IV
CorticosteroidsDrug
IV \& oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnosis of new onset Diabetes Mellitus as per ADA criteria at any point up to 24 weeks after kidney transplantationTime frame: up to 6 months
Locations
100 sites in 24 countries. Site status is shown where the registry gives one.
Site not named
Perth, Australia
Site not named
Sydney, Australia
Site not named
Sydney, Australia
Site not named
Brussels, Belgium
Site not named
Brussels, Belgium
Site not named
Leuven, Belgium
Site not named
Liège, Belgium
Site not named
Cali, Colombia
Site not named
Brno, Czechia
Site not named
Hradec Králové, Czechia
Site not named
Olomouc, Czechia
Site not named
Prague, Czechia
Site not named
Tartu, Estonia
Site not named
Helsinki, Finland
Site not named
Bordeaux, France
Site not named
Cité Nord, France
Site not named
D'Angers, France
Site not named
Le Puytren, France
Site not named
Montpellier, France
Site not named
Nantes, France
Site not named
Nice, France
Site not named
Paris, France
Site not named
Rennes, France
Site not named
Rouen, France
Site not named
Strasbourg, France
Site not named
Suresnes, France
Site not named
Aachen, Germany
Site not named
Bonn, Germany
Site not named
Düsseldorf, Germany
Site not named
Essen, Germany
Site not named
Halle, Germany
Site not named
Kaiserslautern, Germany
Site not named
Mannheim, Germany
Site not named
München, Germany
Site not named
Regensburg, Germany
Site not named
Rostock, Germany
Site not named
Debrecen, Hungary
Site not named
Szeged, Hungary
Site not named
Ancona, Italy
Site not named
Bologna, Italy
Showing 40 of 100 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.